Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
57,050.15 +1,025.48 (+1.83%) CMC Crypto 200
1,185.52 -23.17 (-1.92%)
AEON Biopharma, Inc. (AEON)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 38.25M |
| Enterprise value | 41.98M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 97.16 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 201.68 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.40 |
| 52-week change 3 | -89.37% |
| S&P500 52-week change 3 | 26.25% |
| 52-week high 3 | 17.1700 |
| 52-week low 3 | 0.9180 |
| 50-day moving average 3 | 1.8112 |
| 200-day moving average 3 | 6.1619 |
Share statistics
| Avg vol (3-month) 3 | 85.37k |
| Avg vol (10-day) 3 | 41.22k |
| Shares outstanding 5 | 39.12M |
| Implied shares outstanding 6 | 39.12M |
| Float 8 | 16.07M |
| % held by insiders 1 | 40.15% |
| % held by institutions 1 | 24.26% |
| Shares short (14 Jun 2024) 4 | 146.76k |
| Short ratio (14 Jun 2024) 4 | 1.81 |
| Short % of float (14 Jun 2024) 4 | 0.67% |
| Short % of shares outstanding (14 Jun 2024) 4 | 0.38% |
| Shares short (prior month 15 May 2024) 4 | 123.49k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -50.07M |
| Net income avi to common (ttm) | -137.01M |
| Diluted EPS (ttm) | -0.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.56M |
| Total cash per share (mrq) | 0.04 |
| Total debt (mrq) | 5.29M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.16 |
| Book value per share (mrq) | -5.20 |
Cash flow statement
| Operating cash flow (ttm) | -45.37M |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.